LIFT BioSciences
Developing alpha neutrophil therapy
- B2B
About LIFT BioSciences
Innovative biotech developing alpha neutrophil cell therapy to target solid tumors, enhance immune response, and achieve lasting immunity in cancer patients
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- london, England, United Kingdom
- Founded
- 2016
- Revenue
- $6M – $47.7MTamtam estimate
- Website
- liftbiosciences.com
LIFT BioSciences at a glance
LIFT BioSciences is a B2B company in the Biotechnology Research industry, headquartered in london, England, United Kingdom.
LIFT BioSciences was founded in 2016.
LIFT BioSciences has 11–50 employees.
LIFT BioSciences's revenue is $6M – $47.7M (Tamtam estimate).
Frequently asked questions about LIFT BioSciences
What is LIFT BioSciences's revenue?
Tamtam estimates LIFT BioSciences's annual revenue at $6M – $47.7M.
How many employees does LIFT BioSciences have?
LIFT BioSciences has 11–50 employees.
Where is LIFT BioSciences headquartered?
LIFT BioSciences is headquartered in london, England, United Kingdom.
Selling to companies like LIFT BioSciences?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies